04/19/2024
3:25 PM | Beam Therapeutics (Filer)
| Form ARS | |
04/19/2024
3:15 PM | Beam Therapeutics (Filer)
| Form DEF 14A | |
04/19/2024
3:20 PM | Beam Therapeutics (Filer)
| Form DEFA14A | |
04/04/2024
7:56 PM | Beam Therapeutics (Subject)
Ciaramella Giuseppe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
7:57 PM | Beam Therapeutics (Subject)
Burrell Terry-Ann (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
7:57 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
7:55 PM | Beam Therapeutics (Subject)
Simon Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
04/04/2024
7:56 PM | Beam Therapeutics (Subject)
Bellon Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
6:39 PM | Beam Therapeutics (Issuer)
Burrell Terry-Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:40 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:43 PM | Beam Therapeutics (Issuer)
Simon Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:33 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:36 PM | Beam Therapeutics (Issuer)
Evans John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:22 PM | Beam Therapeutics (Subject)
Simon Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
3:10 PM | Beam Therapeutics (Issuer)
Simon Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:10 PM | Beam Therapeutics (Issuer)
Burrell Terry-Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
5:13 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
6:40 AM | Beam Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
6:22 AM | Beam Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
5:43 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
1:34 PM | Beam Therapeutics (Issuer)
FMR LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:18 PM | ARCH Venture Fund IX, L.P. (Filed by)
Beam Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
2:38 PM | Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Beam Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/06/2024
6:27 AM | Beam Therapeutics (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
| Form SC 13G/A | |
01/31/2024
3:47 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
3:00 PM | ARK Investment Management LLC (Filed by)
Beam Therapeutics (Subject)
| Form SC 13G/A | |
01/25/2024
3:59 PM | Beam Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/24/2024
7:42 AM | Beam Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
01/08/2024
5:55 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:30 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
9:56 AM | Beam Therapeutics (Issuer)
FMR LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:10 PM | Beam Therapeutics (Issuer)
Shaw Christi (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/14/2023
3:15 PM | Beam Therapeutics (Issuer)
Shaw Christi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:20 PM | Beam Therapeutics (Subject)
Bellon Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023
6:30 AM | Beam Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
6:00 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2023
3:30 PM | Beam Therapeutics (Issuer)
Simon Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
5:44 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
3:41 PM | Beam Therapeutics (Subject)
Simon Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/19/2023
7:50 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Will this $2 AI stock double overnight? (Ad) It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract.
What's more, this groundbreaking firm is trading for less than $2 a share! Click here to learn more >>> |
10/04/2023
3:30 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
2:20 PM | Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G | |
08/08/2023
6:30 AM | Beam Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023
6:11 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2023
5:36 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
5:31 PM | Beam Therapeutics (Subject)
Ciaramella Giuseppe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/08/2023
3:31 PM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
6:31 AM | Beam Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2023
6:00 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
